As we recently announced, the Veintree team, along with INSP_CI and Kyrneo, were at the Geneva Health Forum on May 27, 28 and 29 to share a major public health breakthrough in Côte d'Ivoire.
Over the past six years, the team at the Institut National de Santé Publique de Côte d'Ivoire (INSP_CI, National Institute of Public Health of Côte d’Ivoire) has undertaken an ambitious project: digitizing and analyzing the medical records of over 60,000 people diagnosed with Type 2 diabetes, in line with World Health Organization (WHO) guidelines, and in partnership with economist Mrs. Amichia and the Kyrneo and Veintree teams.
Thanks to our unwavering determination, associated with a great deal of meticulous work, we have succeeded in creating a database that offers interesting prospects for the management of diabetes and the contribution of artificial intelligence. This database not only makes it possible to monitor the effectiveness of treatments, but also analyze trends in the disease, predict its progression as well as its individual and global costs, and above all, identify and set up opportunities for effective prevention.
One of the most exciting aspects of this project is the use of innovative technologies that facilitate data collection and analysis, through our partner Kyrneo's technology.
Thanks to Veintree’s technology, we will be implementing an authentication system based on palm recognition and tokenization, in compliance with the strictest data protection standards. This will enable us to guarantee the confidentiality of information while minimizing any data anomalies or errors.
We have been able to identify effective treatment regimens and present them to the doctors in charge, which improves patient follow-ups. Most importantly, we will be able to involve patients in the management of their health by enabling them to compare their own results to similar cases. By using evidence-based data and advanced analysis tools, we can provide personalized recommendations to patients, helping them to make informed decisions about their health.
The results of our work serve as the basis for broader and more focused research in support of “5P” medicine: personalized, preventive, predictive, participatory, and based on proof.